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MocR

the PLP-binding site of type I aminotransferases, no aminotransferase activity has been detected for GabR (9). To our
knowledge, the existence of PLP in MocR/GabR-type transcription regulators is the only case known in nature where PLP
functions as an effector in transcription regulation, including
other reports of the MocR/GabR-type regulators DdlR, PdxR,
and TauR (10–15). A previous report on GabR has shown that a
second metabolite pair of pyridoxamine-5′-phosphate (PMP)
and SSA could also cause transcription activation upon binding
to GabR (8). In fact, the first half of the “Ping-Pong” transamination catalyzed by GABA-AT (Scheme 1 and Scheme S1)
converts PLP and GABA to PMP and SSA reversibly (16). It was
Significance
Regulator of the gabTD operon and its own gene (GabR)
is an intriguing case of molecular evolution, displaying the
evolutionary lineage between a pyridoxal-5′-phosphate (PLP)dependent aminotransferase and a regulation domain of a
transcription regulator. Here, PLP’s native function is not a
catalytic coenzyme, but an effector of transcription regulation.
The chemical species of GabR-PLP–GABA, which is responsible
for GabR-mediated transcription activation, has been revealed
as a stable external aldimine formed between PLP and GABA
by a crystal structure with further support from results in
mechanistic crystallography, NMR spectroscopy, and biological
assays using both GABA and a GABA analog, (S)-4-amino-5fluoropentanoic acid (AFPA), as a molecular probe. Our results
provide mechanistic insights for a currently understudied
Rhizobium meliloti rhizopine catabolism regulator (MocR)/
GabR subfamily of bacterial transcription regulators.
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B

acterial transcription regulators are often directly responsive
to the changes in metabolite concentrations (1, 2). The
regulator of the gabTD operon and its own gene (GabR) responds to the increase of γ-aminobutyric acid (GABA) concentration in bacterial cells (3) and up-regulates glutamate
regeneration from GABA. Belonging to the Rhizobium meliloti
rhizopine catabolism regulator (MocR)/GabR subfamily in the
repressor of the Bacillus subtilis gluconate operon (GntR) family
of bacterial transcription regulators (2–5), GabR-type regulators
characteristically have a large C-terminal effector-binding/
oligomerization (Eb/O) domain, which is homologous to the
type I aminotransferases (6), and a small N-terminal “wingedhelix–turn–helix” (wHTH) DNA-binding domain (7). In B. subtilis,
GabR represses its own transcription (3, 8). With both pyridoxal5′-phosphate (PLP) and GABA bound, GabR activates the transcription of two genes, gabT and gabD, that encode the enzymes
GABA aminotransferase (GABA-AT) and succinic semialdehyde
(SSA) dehydrogenase, respectively, forming a pathway for glutamate regeneration from GABA (3, 8).
Previously, we have reported the crystal structures of fulllength GabR as a “head-to-tail” dimer (9), in which electron
density supported the existence of PLP bound to K312 of the
Eb/O domain in the form of an internal aldimine. Although the
PLP-binding site of GabR is largely conserved compared with

www.pnas.org/cgi/doi/10.1073/pnas.1703019114

Author contributions: R.W., R.S., B.R.B., R.B.S., D.R., and D.L. designed research; R.W., R.S.,
B.R.B., J.I.J., H.V.L., H.J.S.L., M.F., and D.L. performed research; R.W., J.I.J., H.V.L., R.B.S.,
and D.L. contributed new reagents/analytic tools; R.W., R.S., B.R.B., H.V.L., G.A.P., D.R.,
and D.L. analyzed data; and R.W., R.B.S., G.A.P., D.R., and D.L. wrote the paper.
Reviewers: K.L.K., Otago; and M.T., University of California, Davis.
The authors declare no conflict of interest.
Data deposition: The atomic coordinates and structure factors have been deposited in the
Protein Data Bank, www.pdb.org (PDB ID codes 5T4J, 5T4K, and 5T4L).
1

Present address: Feil Family Brain and Mind Research Institute, Weill Cornell Medical
College, New York, NY 10065.

2

Present address: Department of BioMolecular Sciences, the University of Mississippi
School of Pharmacy, University, MS 38677.

3

Present address: Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, NY 10032.

4

To whom correspondence may be addressed. Email: dliu@luc.edu or gpetsko@med.
cornell.edu.

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1703019114/-/DCSupplemental.

PNAS | April 11, 2017 | vol. 114 | no. 15 | 3891–3896

BIOCHEMISTRY

The Bacillus subtilis protein regulator of the gabTD operon and its
own gene (GabR) is a transcriptional activator that regulates transcription of γ-aminobutyric acid aminotransferase (GABA-AT;
GabT) upon interactions with pyridoxal-5′-phosphate (PLP) and
GABA, and thereby promotes the biosynthesis of glutamate from
GABA. We show here that the external aldimine formed between
PLP and GABA is apparently responsible for triggering the GabRmediated transcription activation. Details of the “active site” in the
structure of the GabR effector-binding/oligomerization (Eb/O) domain suggest that binding a monocarboxylic γ-amino acid such as
GABA should be preferred over dicarboxylic acid ligands. A reactive GABA analog, (S)-4-amino-5-fluoropentanoic acid (AFPA), was
used as a molecular probe to examine the reactivity of PLP in both
GabR and a homologous aspartate aminotransferase (Asp-AT)
from Escherichia coli as a control. A comparison between the structures of the Eb/O–PLP–AFPA complex and Asp-AT–PLP–AFPA complex revealed that GabR is incapable of facilitating further steps of
the transamination reaction after the formation of the external
aldimine. Results of in vitro and in vivo assays using full-length
GabR support the conclusion that AFPA is an agonistic ligand capable of triggering GabR-mediated transcription activation via formation of an external aldimine with PLP.

5T4K, and 5T4L, respectively. The Eb/O–PLP–GABA and Eb/
O–PLP–AFPA complex structures were solved with molecular
replacement and refined at 2.23 Å resolution and 2.25 Å resolution, respectively. The structure of the Asp-AT–PLP–AFPA
complex was also solved with molecular replacement and refined
at 1.53 Å resolution. The overall structure of the Eb/O domain
retains the same head-to-tail homodimer architecture as in the
full-length GabR and type I aminotransferases (Fig. 1).
Details of the Effector Binding Site in the GabR Eb/O Domain and
Schiff Base Formation Between PLP and GABA. In the effector-

Scheme 1. GabR effectors and the GABA-AT reaction that is under GabRmediated regulation are illustrated. The effectors for GabR-mediated transcription activation are shown in dashed boxes. The GABA-AT reaction in a
“Ping-Pong” mechanism is shown in the solid box.

hypothesized that certain step(s) of the aminotransferase reaction might be required to trigger GabR-mediated transcription
activation (8). Such a hypothesis has not been thoroughly proven,
and the chemical identity of the GabR-PLP–GABA complex that
results in transcription activation was most recently proposed as
an external aldimine based solely on an observed spectroscopic
signal and chemical logic (17), but no structural evidence is
known. In the same paper, the dissociation constant of PLP is
reported as 1.20 μM and the dissociation constant of GABA in
the presence of PLP was reported as 2.6 mM. Using X-ray
crystallography, NMR spectroscopy, and biological assays, an
external aldimine species is reported here that is formed between
PLP and GABA when both are bound to the effector-binding
site of GabR and is apparently responsible for triggering GabRmediated transcription activation.
Results and Discussion
Protein Purification. All proteins, including Escherichia coli aspartate aminotransferase (Asp-AT), were expressed and purified with supplemented PLP (∼1 mM), giving a yellow color
resulting from the internal aldimine formed between PLP and a
conserved lysine.

binding pocket of the Eb/O domain, the omit map difference
electron density (Fo-Fc) revealed the existence of a Schiff base
formed between PLP and GABA (Fig. 2A). The ligands are refined with occupancies of 1 in each effector-binding site, indicating
a stoichiometry of 1 for each monomer. Two basic residues,
R207 and R430, along with H114 from the same subunit, interact
with the carboxylate of the GABA moiety. In the previously published structure of the GABA-AT–PLP–aminooxyacetate (AOA)
complex (Fig. 2B), the PLP-AOA adduct mimics the PLP-GABA
external aldimine, whose carboxylate interacts with one of the
conserved arginine residues (R141) (19). Compared with the homologous type I aminotransferases, such as GABA-AT (Fig. 2B),
GabR is missing one (R141 in GABA-AT) of the two conserved
arginines, which are involved in binding to dicarboxylic acid
substrates (19, 20), such as L-glutamate or 2-ketoglutarate, in
the second half of a typical transamination reaction (Scheme 1).
This observed structural difference suggests that GabR has evolved
to recognize monocarboxylic acids, such as GABA, preferentially
and to orient the ligand in favor of forming a Schiff base with PLP.
Interestingly, the conserved basic residues in GabR are not
aligned with GABA-AT residue R141, which had been proposed
to interact with the GABA carboxylate (19, 21). Although the
AOA-PLP adduct, which mimics the GABA-PLP in the E. coli
GABA-AT structure, binds to the active site in an anticonformation, the PLP-GABA Schiff base in GabR is in a gauche conformation (Fig. 3). The dihedral torsional angle of C2C1-O-N in the PLP-AOA “structural mimic” is measured to be
157° (23° off from an ideal anticonformation) in UCSF Chimera.
In the Eb/O–PLP–GABA complex structure (Fig. 3A), the dihedral torsional angle of Cα-Cβ-Cγ-N in the PLP-GABA Schiff
base was measured to be 77.3° (17.3° off from an ideal gauche
conformation) in UCSF Chimera. Compared with the anticonformation, the gauche conformation is of higher energy and a
relatively minor conformation for GABA molecules in an aqueous
environment in the cell.
In all PLP-dependent enzymes, a conserved lysine forms an
internal aldimine with PLP in its resting form and acts as a key

Crystallography of GabR Eb/O Domain and Asp-AT Complexed with
Ligands. Crystallization of full-length GabR in the presence of

GABA was not successful, so a truncated version (residues 88–
479) lacking the helix–turn–helix domain was produced. This
Eb/O domain was expressed, purified, and cocrystallized with PLP
and GABA. Crystals of three complexes with PLP-ligand adducts
bound, the Eb/O domain with a PLP-GABA adduct, a PLP–(S)4-amino-5-fluoropentanoic acid (AFPA) adduct, and Asp-AT
with a PLP-AFPA adduct, were obtained by cocrystallization.
X-ray crystal structures of all three complexes were determined,
refined, and converged with statistics shown in Table S1. In all
three cases, a Schiff base adduct was formed and an appropriate
model was built into the electron density maps (Fo-Fc) in the
final rounds of refinement. The formed adduct was confirmed by
the simulated annealing omit difference maps (Fo-Fc) generated
in Phenix (18). The final models for the Eb/O–PLP–GABA, Eb/
O–PLP–AFPA, and Asp-AT–PLP–AFPA complexes have been
deposited in the Protein Data Bank (PDB) with ID codes 5T4J,
3892 | www.pnas.org/cgi/doi/10.1073/pnas.1703019114

Fig. 1. Head-to-tail dimers of the full-length GabR (PDB ID code 4N0B),
Eb/O domain of GabR, and Asp-AT. Bound PLPs are shown in spheres. (A) In
the full-length GabR, the Eb/O domains are in red, the flexible linker regions
are in orange, and the DNA-binding domains are in blue. (B) Overlay of two
dimeric structures of the GabR Eb/O domain in complexes with GABA (magenta) and AFPA (green). (C) Dimeric structure of E. coli Asp-AT (PDB ID code
1SFF, cyan).
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catalytic residue during catalytic reactions, such as in the first
half of the “Ping-Pong” transamination (6) (Scheme S1). The
conserved K312 (9) (Fig. 4) was previously proven to be essential
for GabR’s function, although the catalytic capacity to facilitate
transamination has never been detected for GabR (8). In the Eb/
O–PLP–GABA complex structure (Fig. 2A), Y281 is observed to
block K312 from accessing the PLP-GABA Schiff base, preventing reformation of the internal aldimine as well as further
transamination-like catalysis, in which the freed catalytic lysine
would deprotonate the carbon adjacent to the nitrogen atom of
the GABA-PLP adduct (19, 22) (Scheme S1). As a result, GabR
is unlikely to catalyze the first half of the transamination reaction
shown in Scheme 1. As we previously reported (9), in the absence of GABA, Y281 is found in a different orientation,
allowing internal aldimine formation (Fig. 4). The observed
obstruction by Y281 supersedes the previous speculation that
GabR’s inability to stabilize the external aldimine might be the
reason for the lack of observed transaminase activity (9).
External Aldimine as the Final State of GabR-Mediated Reaction. The
Eb/O–PLP–GABA complex structure at 2.23 Å resolution could
not allow us to distinguish between external aldimine and ketimine (Scheme S1) for the chemical identity of the PLP-GABA
Schiff base observed. Therefore, we used a mechanism-based
inactivator, AFPA, which was designed to inactivate PLPdependent aminotransferases irreversibly (23), as a molecular
probe. A previously proposed inactivation mechanism of an
aminotransferase, mammalian GABA-AT, by AFPA is shown
in Scheme 2. Once a typical aminotransferase reaction progresses beyond the external aldimine 1 stage, the AFPA moiety
releases the fluoride ion, resulting in a reactive intermediate.
Eventually, AFPA inactivates the PLP-dependent aminotransferase via a ternary adduct, in which the AFPA moiety is covalently
linked to both PLP and the catalytic lysine, or alternatively forms
external aldimine 3. The catalytic lysine freed after the formation
of the external aldimine 1 plays a critical role in assisting
the irreversible inactivation of the PLP-dependent enzyme. The
formation of the proposed ternary adduct should provide evidence that the reaction between AFPA and PLP can progress
beyond the external aldimine 1, reaching quinonoid or ketimine
intermediates (Scheme 2 and Scheme S1). In contrast, the intact
fluorine group of AFPA should indicate that the reaction could
not proceed beyond the formation of the external aldimine 1.
Due to the overall desirable crystallographic behavior of E. coli
Asp-AT, we chose it as a control for the cocrystallization experiment with AFPA. E. coli Asp-AT, a homolog of the GabR Eb/O
domain, has previously been used successfully as a model enzyme
to study mechanism-based inactivators of PLP-dependent enzymes (24–26).
Wu et al.

Fig. 3. GABA moiety displays a Gauche conformation. (A) GABA bound in
the Eb/O domain is in a gauche conformation. The PLP-GABA external
aldimine is shown in stick and ball form. The Cγ atom is placed (hidden)
behind the Cβ atom, in the same orientation as the Newman projection for
the dihedral torsional angle Cα-Cβ-Cγ-N in PLP-GABA, shown in the gauche
conformation. (B) AOA-PLP imine bound in E. coli GABA-AT (PDB ID code
1SFF) mimicking the PLP-GABA Schiff base is shown in ball and stick form.
The O atom is placed (hidden) behind the C1 atom in the same orientation as
the Newman projection for the dihedral torsional angle C2-C1-O-N in PLPAOA, shown in the anticonformation.
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Fig. 2. PLP and GABA bound to the truncated Eb/O domain. (A) Simulated
annealing omit map (Fo-Fc) is shown around the PLP-GABA Schiff base at 3σ.
(B) Eb/O–PLP–GABA complex in comparison to GABA-AT with AOA bound to
PLP mimicking the PLP-GABA external aldimine (green, PDB ID code 1SFF).

Both the GabR Eb/O domain and Asp-AT were cocrystallized
with PLP and AFPA. The structure of the Eb/O–PLP–AFPA
complex (refined at 2.25 Å resolution) confirms the formation of
an external aldimine with the fluorine atom intact in the final
adduct (Fig. 5A). To validate the existence of the fluorine atom,
extra rounds of refinement were done after deletion of the
fluorine atom; the omit map difference electron density (Fo-Fc)
strongly supports the presence of the fluorine atom in the
complex. Residue Y281 is observed to be in the same position as
in the Eb/O–PLP–GABA complex structure (Fig. 4), preventing
the access of K312 to the PLP-AFPA Schiff base, which could
otherwise potentially push the reaction further along the proposed inactivation pathway (Scheme 2).
This electron density could also be fitted with another atom, so
additional validation was used to establish its identity. It is
chemically plausible that a hydroxyl or water could react with the
reactive intermediate and replace the eliminated fluorine group;
the resulting adduct 3 would be structurally similar to the external aldimine proposed here (adduct 1 in Scheme 2). At the
2.25 Å resolution obtained for the Eb/O–PLP–AFPA complex
structure, it is impossible to distinguish adduct 3 from adduct
1 even with the omit map difference electron density (Fo-Fc)
validation shown (as green mesh) in Fig. 5A. Pathway b in Scheme
2 and adduct 3 have never previously been proven in studies of
AFPA inactivation. Nevertheless, the AFPA-treated protein sample was subjected to fluorine NMR spectroscopy to eliminate the
possibility of an alternative adduct (adduct 3 in Scheme 2, via
pathway b in Scheme 2). The results are shown in Fig. S1. Fig. S1A
is the fluorine NMR spectrum that shows a triplet of doublets (J1 =
25.3 Hz, J2 = 21.4 Hz), because the fluorine atom is split by its
two neighboring hydrogen atoms and then split again by another
hydrogen atom on the adjacent carbon in the external aldimine
form. Fig. S1B represents the proton-decoupled fluorine NMR
spectrum that shows a singlet, because the fluorine atom and the
protons are decoupled. As concluded, the fluorine atom remains
intact in the same environment as intact AFPA, even after treatment with a saturated amount of GabR protein.
As a positive control, the structure of the Asp-AT–PLP–AFPA
complex (refined at 1.53 Å resolution) showed that the proposed
ternary adduct 2 has formed via pathway a in Scheme 2 (Fig. 5B),
indicating that the catalytic actions of the conserved lysine have
occurred in Asp-AT but not in the GabR Eb/O domain. On
the basis of structural information and NMR results, it was

Scheme 2. Proposed reaction mechanism of AFPA. The green dashed box
(1) shows the final adduct in the GabR Eb/O domain, the red dashed box (2)
shows the expected adduct for Asp-AT, and the blue dashed box (3) indicates
an alternative external aldimine species.

concluded that the external aldimine 1 is the final chemical species
when both PLP and AFPA are bound to the GabR Eb/O domain.
The obtained results using AFPA as a molecular probe suggest
that the observed Schiff base in the Eb/O–PLP–GABA complex
structure is also an external aldimine.
For aminotransferases in general, the external aldimine intermediate can be transiently observed spectroscopically (27).
However, mutation of a catalytic residue (28) or chemical
modification of the ligands, such as the amino acid (19) or PLP
(29, 30), was required to trap a stable external aldimine in an
aminotransferase. GabR is a protein reported to be capable of
forming a stable external aldimine between PLP and GABA for
its function in transcription regulation. Our results are consistent
with the ability of another group to detect the external aldimine
of GabR using spectroscopic approaches (17). Spectroscopic
changes, consistent with the formation of external aldimine, were
also reported for DdlR (11). Only mild global conformational
changes are introduced in the PLP-bound Eb/O domain of GabR
upon binding to GABA and formation of the external aldimine.
A least squares structural comparison revealed that the Eb/O
domains of the GabR-PLP dimer (PDB ID code 4N0B) aligned
well with the Eb/O domains of the Eb/O–PLP–GABA complex
or the Eb/O–PLP–AFPA complex, with rmsd values for Cα
atoms around 1.12 Å and 1.13 Å, respectively. Conformational
changes could be more pronounced in the linker region between
the Eb/O and wHTH domains, and within the wHTH domains in
the full-length dimeric GabR; these conformational changes
likely contribute to the triggering of transcription activation.
Functional Significance of External Aldimine Formation. To extrapolate the functional interpretation from the GabR Eb/O domain
to the full-length GabR, both in vivo and in vitro assays were
conducted to compare the biological effects of GABA and
AFPA. When examining GabR-mediated activation in vivo using
a gabT/lacZ fusion (3) (Fig. 6A), both GABA and AFPA triggered GabR-mediated transcription activation in B. subtilis cells.
The time course of transcription activation was measured and
plotted as the calculated Miller units over a 450-min period after
addition of the effectors (Fig. 6 A and B). The growth of the
culture was also plotted at the same time points as the Miller unit
measurements (Fig. 6C). The results clearly demonstrate that
both AFPA and GABA cause transcription activation at 200 min
and beyond. Although the culture grew better after 300 min in
3894 | www.pnas.org/cgi/doi/10.1073/pnas.1703019114

the presence of GABA than it did in the presence of AFPA, the
gene activation level was actually more pronounced for AFPA
than for GABA after 300 min.
In vitro, GabR, PLP, RNA polymerase, and the gabT promotercontaining DNA fragments were mixed with radioactively labeled nucleotides as described previously (8). The gabT transcripts, which are indicated as the appearance of the newly
synthesized P32-labeled bands, were formed upon addition of
either GABA or AFPA (Fig. 6D) proportional to the amount of
the effector added. AFPA triggered the GabR-mediated transcription activation in vitro with a higher potency than did
GABA. The GabR-PLP–AFPA complex may be a better transcriptional activator than the GabR-PLP–GABA complex. This
interpretation could explain the long-lasting activation effect
caused by AFPA shown in the in vivo experiments after 300 min
(Fig. 6 A–C). Overall, we conclude that AFPA activates the
transcription of the gabT promoter via the same chemical principle, which is the formation of the external aldimine, as GABA
does in B. subtilis. The activation of transcription by GabR induced by GABA has also been reported in Bacillus thuringiensis,
indicating that this function is not unique to B. subtilis (31).
Conclusions
Using crystallography, we have shown that PLP bound to the
GabR Eb/O domain reacts with the effector GABA to form a
stable external aldimine, which apparently triggers the transcription from the gabT promoter in B. subtilis. This conclusion
is consistent with the published spectroscopic analysis of GabR
(17) and offers an explanation for the previous results that
the effector pair of PMP and SSA can also trigger GabRmediated transcription activation in vitro (8). Through a reverse transamination-like reaction (Scheme S1), SSA and PMP
can potentially form a Schiff base, presenting a structure similar
to the PLP-GABA external aldimine (8). However, SSA and
PMP may not work as an actual effector pair in vivo. With an
evolutionarily modified PLP-GABA–binding site, the GabR Eb/O
domain is capable of preferentially binding to GABA and forming

Fig. 4. Comparison of the external aldimine vs. internal aldimine in GabR.
External aldimine Schiff bases (magenta and cyan), internal aldimine Schiff base
with K312 (gray), and Y281 are shown in stick form. Labels and carbon atoms
for internal aldimine (PDB code ID 4N0B) are in black and gray, respectively.
Labels and carbon atoms for the Eb/O–PLP–GABA complex are in magenta.
Labels and carbon atoms for the Eb/O–PLP–AFPA complex are in cyan.

Wu et al.

an external aldimine. To perform the role of a transcription regulator, GabR employs Y281 to subdue the Eb/O domain’s catalytic potential by stabilizing the external aldimine formed and
preventing its further modification.
Materials and Methods
Materials. Chemicals for the assays were purchased from Fisher Scientific and
Sigma–Aldrich. Cloning vectors were obtained from Integrated DNA Technologies. E. coli BL21 (DE3) cells were purchased from New England BioLabs.
Bacterial growth media and antibiotics were obtained from Fisher Scientific
and Sigma–Aldrich. Crystallization screen solutions and other crystallization
supplies were purchased from Hampton Research and Emerald Bio. All
chemicals were of the highest quality available.
Truncation and Cloning of GabR Eb/O Domain. The sequence coding for the
GabR Eb/O domain was amplified by PCR using previously cloned full-length
GabR (in pETite vector from Lucigen) as the template (9), the specific oligonucleotides as primers (forward primer designed as GAAGGAGATATACATATGATCGACCAGAGCGATTGGATA and reverse primer designed as
GTGATGGTGGTGATGATGATCCCCTGTAACGGGGATTTT), and Phusion HF
DNA polymerase, following the manufacture’s instructions. The thermocycler
program used included an initial denaturation for 120 s at 95 °C; 35 cycles at
95 °C for 30 s, 50 °C for 60 s, and 72 °C for 60 s; and a final extension at 72 °C
for 5 min. The PCR product was inserted into a pETite vector for recombinant
expression of GabR Eb/O domain protein with a C-terminal His6-tag.
Protein Expression and Purification. Full-length GabR protein and L-aspartate
aminotransferase from E. coli were expressed and purified as described (8).
The GabR Eb/O domain was overexpressed in E. coli and purified using a
similar method. Transformed E. coli BL21 (DE3) cells were grown in 1 L of LB
supplemented with 50 μg/mL kanamycin at 37 °C and 250 rpm using a
MaxQ6000 shaker bath incubator (Thermo Fisher Scientific) until OD600 nm
reached ∼0.6. Protein expression was induced by the addition of 0.5 mM
isopropyl-beta-D-1-thiogalactopyranoside. Cells were incubated at 25 °C and
harvested after 16 h by centrifuging using a JA10 rotor (Beckman) at
4,800 rpm and 4 °C for 10 min. The cell paste was resuspended in the lysis
buffer containing 1× PBS and 10 mM imidazole (pH 8.0), followed by sonication. The resulting suspension was centrifuged twice using a JA20 rotor
(Beckman) at 16,500 rpm and 4 °C for 20 min, and the soluble fraction was
loaded onto a 10-mL His-Trap column (GE Life Sciences) containing Ni2+ and
previously equilibrated with lysis buffer. Elution of the retained proteins was
achieved with a linear imidazole gradient (25-column volume, 10–485 mM).
Fractions containing the truncated EB/O domain were pooled, concentrated
to 2 mL, and loaded onto a 16/60 Superdex 200 size exclusion column
(GE Life Sciences) that was previously equilibrated with 84% elution buffer.
Fractions containing enzyme were pooled, concentrated, and used immediately after exchanging into suitable buffers for crystallization and biological
assays. The wild-type Asp-AT was overexpressed and purified with the protocol
used by Onuffer and Kirsch (32).
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Phasing, Model Building, and Refinement. Diffraction data were phased with
molecular replacement using the program Phaser (34) in the CCP4 software
suite (35). A previously solved full-length GabR structure (9), truncated to
contain residues 107–479, was used as the search model. The previously
solved AspAT model 2Q7W (25) was used as the search model for the E. coli
Asp-AT–PLP–AFPA structure. Rigid body refinement followed by restrained
refinement was carried out in Refmac (36). Model building was conducted
using the program Coot (37). Iterative rounds of model building and refinement generated the final coordinates. The external aldimine ligands,
PLP-GABA or PLP-AFPA, were removed from the model; the model without a
ligand was refined in Phenix using simulated annealing refinement. The
starting temperature was 5,000 K, the final temperature was 300 K, and the
annealing process was conducted in 50 steps with a cooling rate of 100° per
step. The SA OMIT map was then generated after the above refinement.
In Vivo and in Vitro Assays for GabR-Dependent Transcription Activation. The
in vivo assay was conducted as previously described (8), using GABA or
AFPA as an effector (0.625–20 mM). The expression signal was detected using
ONPG (ortho-nitrophenyl-β-galactoside) as a substrate for the β-galactosidase
(lacZ gene product) generating a spectroscopic signal at 420 nm. The time
course was measured and plotted over a 200-min period. Each point is the
average value of triplicate measurements. For each measurement, the Miller
units were calculated using the following equation: Miller Units = ðO.D.420Þ=
½ðO. D.600Þ × Time × 1.25 × Volume, Volume = 0.8 ml. In vitro GabR-dependent
RNA polymerase reactions were performed as previously described (8). The

Fig. 6. Biological effects of GABA and AFPA. (A) Expression of gabT/lacZ is
indicated by calculated Miller units over time. The calculated Miller units
of the culture without addition of GABA or AFPA were no higher than 2.
(B) Self-developed film indicating the newly synthesized gabT mRNA.
(C) Culture growth (indicated with O.D.600 values) while supplemented
with GABA or AFPA. (D) Lane 1: control without GABA or AFPA. Lanes 2–7:
GABA added at concentrations of 0.625, 1.25, 2.5, 5, 10, and 20 mM, respectively. Lanes 8–13: AFPA added with concentrations of 0.625, 1.25, 2.5,
5, 10, and 20 mM, respectively.
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Fig. 5. AFPA as a molecular probe in the Eb/O domain and in Asp-AT (as a
control). (A) PLP-AFPA external aldimine is bound to the EB/O domain. Two
sets of simulated annealing electron density omit maps (Fo-Fc) are shown. Both
are shown at 3.5 σ. The gray map was generated omitting the complete ligand
adducts, confirming the existence of the ligands. The green map was generated omitting only the fluorine atom, confirming the existence of fluorine
in AFPA. (B) Electron density omit map of the E. coli Asp-AT–AFPA–PLP
complex, generated by omitting AFPA, PLP, and lysine 246 from the calculation. *Indicates that R280 is from a different subunit of the Asp-AT dimer.

Crystallization of the GabR Eb/O and X-Ray Diffraction Data Collection. After
the initial crystallization screen and optimization, the GabR Eb/O domain was
crystallized via hanging drop methods at 25 °C. The hanging drops were
prepared with 1 μL of 12 mg/mL preincubated protein with inhibitor solution
and 1 μL of the reservoir solution that contained 0.1 M Tris (pH 8.5) buffer
and 20% ethanol. Crystals were harvested in about 10 d. For cryocooling,
crystals were transferred to the reservoir solution with 20% glycerol as a
cryoprotectant, and were flash-cooled by plunging in liquid nitrogen. The
cocrystallization of Asp-AT and AFPA was conducted according to previous
studies (24, 25). Diffraction data were collected at GM/CA@APS beamlines
23ID-B and 23ID-D at the Advanced Photon Source (Argonne National Laboratory). The wavelength used for data collection was 1.0332 Å, and diffraction images were recorded on 4 × 4 tiled CCD detectors (Rayonix) with
300 × 300-mm2 sensitive areas. All data were indexed, integrated, scaled,
and merged using HKL2000 (33).

PCR fragment (50 nM) contained the gabR/gabT regulatory region. The total
reaction was carried in transcription buffer containing 40 mM Tris·HCl;
100 mM KCl; 10 mM MgCl2; 5% glycerol; 0.1 mM EDTA; 1 mM DTT; 0.1 mg/mL
BSA with 4 units of RNasin (ribonuclease inhibitor); 150 μM ATP, CTP, and GTP;
20 μM UTP; 0.5–1 μL/Ci 32P-labeled UTP; and 0.02–0.04 unit of E. coli RNA
polymerase. The reaction was incubated at 37 °C for 15 min and terminated by
additional of 4 μL of the 20 mM EDTA, 95% formamide dye solution. The
samples were subsequently heated at 80 °C for 5 min. The samples were then
analyzed without further purification using 7 M urea/5–6% polyacrylamide
DNA sequencing gels. GABA was purchased from Sigma. AFPA was synthesized according to a previous publication (38).

Structural Analysis and Figure Making. All structural analyses were conducted
in Coot (37) and UCSF Chimera (39). Structure comparison of the PLP/amino
acid-binding site was conducted in two steps (Figs. 2B and 6): First, the
overall structural comparison/overlap was conducted in UCSF Chimera
using the Needleman–Wunsch algorithm. Second, manual adjustments
were done by overlapping the pyridine ring of the PLP to achieve better
pattern matching for the conserved key residues in the PLP/amino acidbinding site for comparison. All structural figures were made in UCSF
Chimera.

NMR Spectroscopy. The protein (100 mg) was treated with AFPA. The molar
ratio of the protein and AFPA was 2:1 to minimize free AFPA in the solution.
The sample was concentrated to a volume of 0.4 mL by centrifugation.
Deuterium oxide (0.15 mL) was added, and the solution was transferred to a
5-mm standard NMR tube. Fluorine NMR and proton-decoupled fluorine
NMR spectra were taken at the Northwestern Integrated Molecular Structure
Education and Research Center facility on an Agilent DD2 500-MHz spectrometer with an Agilent 5-mm HFX probe at 26 °C [19F NMR δ 229.87 (td, J1 =
25.3 Hz, J2 = 21.4 Hz), proton-decoupled 19F NMR δ 229.87 (s)].
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